FDA Oncology Biologics Guidance: Nonclinical Safety Studies
This analysis explains the May 2026 FDA draft guidance on nonclinical safety studies for oncology biologics, single-species toxicology, and WoE approaches.
Back to Articles
Articles tagged with “weight-of-evidence”